Doxorubicin and vincristine
-
HLX01 (HanliKang®) is a rituximab biosimilar that showed bioequivalence to reference rituximab in untreated CD20-positive diffuse large B-cell lymphoma (DLBCL) in the phase 3 HLX01-NHL03 study. Here, we report the 5-year follow-up results from the open-label extension part. Patients were randomised to either rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) or HLX01 plus CHOP (H-CHOP) every 21 days for up to six cycles.
10p vikoch 27-06-2024 1 1 Download
-
Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-like chemotherapy is widely used in peripheral T cell lymphoma (PTCL). Here we conducted a phase 2, multicenter, randomized, controlled trial, comparing the efficacy and safety of CEOP/IVE/GDP alternating regimen with CEOP in newly diagnosed PTCL.
13p vibransone 28-03-2024 3 2 Download
-
Little information is available on the outcomes of R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) and R-CVP (rituximab with cyclophosphamide, vincristine and prednisone) in treatment of the elderly patients with non-Hodgkin lymphoma (NHL), especially in Vietnam.
6p nguyenmyhuyen90 04-03-2021 9 1 Download
-
The methods used to treat TVT are cryosurgery, radiotherapy, surgical resection and antineoplastic chemotherapy that is the protocol of choice in routine clinical treatment. Antineoplastic treatment may combine two or more chemotherapeutic agents (for example, vincristine and cyclophosphamide combined with methotrexate), or it can involve a single agent as vincristine (in which case is most effective or doxorubicin).
5p gaocaolon9 22-12-2020 12 2 Download
-
Current treatment of diffuse-large-B-cell lymphoma (DLBCL) includes rituximab, an expensive drug, combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy. Economic models have predicted rituximab plus CHOP (RCHOP) to be a cost-effective alternative to CHOP alone as first-line treatment of DLBCL, but it remains unclear what its real-world costs and cost-effectiveness are in routine clinical practice.
11p vilisa271 22-09-2020 13 0 Download
-
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin’s lymphoma. Bortezomib is the first product to be approved for the treatment of patients with previously untreated MCL, for whom haematopoietic stem cell transplantation is unsuitable, and is used in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP).
11p vimale2711 25-08-2020 11 2 Download
-
The addition of rituximab (R) to CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) -like therapy has improved survival in primary mediastinal B-cell lymphoma (PMBCL) patients. However, these results were obtained in young low risk patients and a reevaluation in an unselected patient cohort is warranted.
9p vidhaka2711 31-07-2020 7 1 Download
-
Rituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is broadly accepted as standard for the treatment of diffuse large B-cell lymphoma (DLBCL). Nevertheless, there is sparsely data concerning the management of elderly patients.
8p vimanila2711 25-06-2020 9 1 Download
-
Present study was conducted at TVCC, LUVAS, Hisar on Twenty-four dogs irrespective of age, breed, sex affected with canine transmissible venereal tumour (TVT). Affected dogs were divided equally into three groups on the basis of treatment with chemotherapeutic drugs viz. vincristine therapy (Group I) and doxorubicin therapy (Group II and III). Vomition, diarrhea, alopecia, allergic nodules and stomatitis were adverse effects of chemotherapy in TVT affected dogs.
7p quenchua6 15-06-2020 11 2 Download
-
The present study was carried out in TVCC, Hisar on twenty-four dogs affected with venereal granuloma. Affected dogs were divided equally into three groups viz. vincristine therapy (Group I) with 7 day cycle and doxorubicin therapy consisting two groups i.e. Group II with 14 day cycle and group III with 21 day cycle. Blood sample collection was done at weekly interval and before administration of drug i.e. Day 0, 7, 14 in Group I, Day 0, 7, 14, 21, 28 in Group II and Day 0, 7, 14, 21, 28, 35, 42 in Group III. Biochemical parameters viz.
5p quenchua6 15-06-2020 14 2 Download
-
The present study was carried out in TVCC, Hisar on twenty-four dogs affected with venereal granuloma. Affected dogs were divided equally into three groups viz. vincristine therapy (Group I) with 7 day cycle and doxorubicin therapy consisting two groups i.e. Group IIwith 14 day cycleand group III with 21 day cycle. Blood sample collection was doneat weekly interval and before administration of drug i.e. Day 0,7,14 in Group I, Day 0,7,14,21,28 in Group II and Day 0,7,14,21,28,35,42 in Group III. Kidney Function Tests viz.
6p quenchua6 15-06-2020 11 1 Download
-
The present study was carried out in twenty-four dogs irrespective of age, breed, sex affected with canine transmissible venereal tumour (TVT). Affected dogs were divided equally into three groups viz. vincristine therapy (Group I) with 7 day cycle and doxorubicin therapy consisting two groups i.e. Group II with 14 day cycle and group III with 21 day cycle. Pre treatment blood sample collection was done before administration of drug i.e. Day 0, 7, 14 in Group I, Day 0, 14, 28 in Group II and Day 0, 21, 42 in Group III. Hematological parameters viz.
6p gaocaolon5 14-06-2020 9 1 Download
-
Present study included twenty-four dogs affected with Canine Transmissible Venereal Tumour (TVT). affected dogs were divided equally into three groups viz. vincristine therapy (Group I) with 7 day cycle and doxorubicin therapy consisting two groups i.e. Group II with 14 day cycle and group III with 21 day cycle and was aimed at diagnosing transmissible venereal tumour (TVT) initially using most common clinical signs and confirmation made by histopathological examination of biopsy tissue.
6p gaocaolon5 14-06-2020 6 1 Download
-
(bq) part 2 book “practical chemotherapy - a multidisciplinary guide” has contents: fludarabine oral, gemcitabine, liposomal daunorubicin, liposomal doxorubicin, mayo regimen, rituximab, prednisolone, mitoxantrone, cyclophosphamide, etoposide, bleomycin, vincristine,… and other contents.
212p tieu_vu15 07-09-2018 29 1 Download